DOCSLIB.ORG

Hoppe-Seyler's Zeitschrift Für Physiologische Chemie

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Hoppe-Seyler's Zeitschrift Für Physiologische Chemie Hoppe-Seyler's Zeitschrift für Physiologische Chemie Band 365 — 2. Jahreshälfte Fortgeführt von A. Kossei, F.Knoop, K.Thomas, F. Lynen, A. Butenandt und G. Weitzel Herausgegeben von K.Decker, W. Stoffel, H.G.Zachau unter Mitwirkung von H. Eggerer, J. Engel, H. Fritz, E. Habermann, E. Helmreich, A. Henschen, B. Hess, N. Hilschmann, H. Hilz, P.W. Jungblut, K. Jungermann, P. Karlson, H. Kleinkauf, H.L. Kornberg, K. Kühn, D. Oesterhelt, K. Rajewsky, K. Sandhoff, R. Schauer, J. Seelig, G. Siebert, H. Sies, H. Simon, E. Truscheit, H. Tschesche, H. Tuppy, V. Ullrich, E. Wecker, H. Wiegandt, Β. Wittmann-Liebold, H. Zahn Redaktion A. Dillmann, G. Peters W DE G 1984 WALTER DE GRUYTER · BERLIN · NEW YORK Gesamtregister 1984 Stichwortregister yV-Acetyl-9-Ö-acetylneuraminic acid, in terminal posi• Adipocytes, (rat) insulin receptor complex, G. Klotz, tion in a disialoganglioside (Grj)la), D.C.Gowda, D.J. Saunders and D. Brandenburg, G. Reuter, A.K. Shukla and R. Schauer, 1247 493 2-Acetyl- 1-0-alkylglycero-phosphocholines, platelet Adipokinetic hormones, purification and amino-acid aggregation and cAMP concentration, I. Η ill mar, composition, G. Gäde, G.J. Goldsworthy, Τ. Muramatsu and Ν. Zöllner, 33 G.Kegel and R.Keller, 393 Acetylcholinesterase (EC 3.1.1.7), (Electrophorus - (of Manduca sexta), amino-acid composition, electricus), fluorescence-labelled inhibitors, R. Ziegler, G. Kegel and R. Keller, 1451 W. Hallenbach and L. Horner, 1475 ADP-Ribosyltransferase (EC 2.4.-.—), Ascaris suum, O-Acetyl-Grjia, s. TV-acetyl-9-O-acetylneuraminic acid R.D.Walter and E. Ossikovski, 805 /3-JV-Acetyl-D-hexosaminidase (EC 3.2.1.52), (in cultured Affinity chromatography, rat liver lysosomes, F.-J. fibroblasts), effect of tilorone, D.K. Gupta, Kamrath, G.Dodt, H.Debuch and G. Uhlen- V. Gieselmann, A. Hasilik and K. v. Figur a, 859 bruck, 539 - (in human monocytes), processing and transport, Agglutinins, s. Ricinus communis agglutinin D.K. Gupta, A. Schmidt, K. v. Figura and Aggregation, of Dictyostelium discoideum, role of A. Hasilik, 867 lumazine, I. Tatischeff, R. Klein and G. Tham, yV-Acetylneuraminic acid, s.a. sialic acids 1255 - 1H-NMR measurement of sialidase substrate specifi• Alces alces alces, (= Northern Elk), amino-acid sequence city, H. Friebolin, W. Baumann, M. Hauck, of hemoglobin, H. Aschauer, H. Wiesner and D.Kurz, R.Wajda, G. Weisshaar, G. Keilich, G. Braunitzer, 1323 D. Ziegler, R. Brossmer and H. v. Nicolai, 1309 Alkaloids, new peptide alkaloid from Discaria febrifuga Acholeplasma laidlawii, purification of Superoxid Mart., R. Herzog, A. Morel, J. Biermann and dismutase, R. Reinards, R. Altdorf and H.-D. W. Voelter, 1351 Uhlenbusch, 577 Amino-acid composition, locust adipokinetic hormones Acid phosphatase (EC 3.1.3.2), tartrate-inhibitable 1 and II, G.Gäde, G.J.Goldsworthy, G.Kegel from placenta fibroblasts, V. Gieselmann, and R.Keller, 393 A. Hasilik and K. v. Figura, 651 - adipokinetic hormone of Manduca sexta (tobacco - (from rat liver microsomes), circadian rhythm, hornworm), R. Ziegler, G. Kegel and R. Keller, effect on NADH 5α-reductase, V. Graef and 1451 S.W.Golf, 1271 Amino-acid derivatives, sensitive identificaton with a Acid-resistant urinary trypsin inhibitors, s. trypsin 32P-labelled Edman reagent, B.E. Ender, H.-G. inhibitors (urinary, acid-resistant) Gassen and W. Machleidt, 839 Acid-stable trypsin inhibitor, s. trypsin inhibitors Amino acids, recovery after protein hydrolysis, (acid-stable) A. Tsugita, F. Vilbois, C. Jone and R. van den Acrosin inhibitor, a new one in human seminal plasma, Broek,343 M.-L. Huhtala, 819 Amino-acid sequence, s.a. sequence homology Activator protein, s. GM2"activator protein - hemoglobin of the goldfish, K. Rodewald and Active-site titration, horse urinary kallikrein, CA.M. G. Braunitzer, 95 Sampaio, M.U. Sampaio and E.S. Prado, 297 - μ-chain-disease protein BOT, S. Barnikol- Acylation, s.a. deacylation Watanabe, E. Mihaesco, C. Mihaesco, H.U. - of human erythrocyte membrane, F. Herbst and Barnikol and N. Hilschmann, 105 V. Rudloff, 525 - anaphylatoxin des-Arg^-CSa, B. Zimmermann and Adder, s. Bids nasicomis (= Horned adder) W. Vogt, 151 Adenosine derivatives, s.a. diadenosine tetraphosphate - hemoglobin of starling, αΑ-, oP- and /3-chains, (Ap4A) W. Oberthür and G. Braunitzer, 159 Adenosine 3',5'-monophosphate, platelet-activating - bovine glutathione peroxidase, W. A. Giinzler, factor, I. Hillmar, T. Muramatsu and G.J. Steffens, Α. Grossmann, S.-M.A. Kim, N.Zöllner, 33 F. Otting, A. Wendel and L. Flohe, 195 1498 Stichwortregister Bd.365(1984) - polypeptide VHIb of cytochrome c oxidase, - human class II histocompatibility antigens, G. Egert, L. Meinecke, G.J. Steffens and G. Buse, 313 F.P.Thinnes, H.Götz, Ε.Pauly, Η.Kratzin, - e- and ^-chains of embryonic pig hemoglobin, C. -y. Yang, S.Kölbel, P. Altevogt, P.Wernet and F. Α. Bieber and G. Braunitzer, 321 N. Hilschmann, 1291 - major hemoglobin component of American Flamingo - hemoglobin of the Northern Elk, Η. Asciiauer, (Phoenicopterus ruber ruber), J. Godovac-Zimmer- Η. Wiesner and G. Braunitzer, 1323 mann and G. Braunitzer, 437 - of murine VK25 and VK27 chains of two mono­ - hemoglobin of the mole rat (Spalax ehrenbergij, clonal antibodies, specific for the group A strepto­ T. Kleinschmidt, E. Nevo and G. Braunitzer, 531 coccal polysaccharide, R. Aebersold, H. Herbst, - rhesus monkey insulin and proinsulin, V.K. Τ. Grütter, J.Y.Chang and D.G.Braun, Naithani, G.J. Steffens, H.S. Tager, G. Buse, 1375 A.H. Rubenstein and D.F. Steiner, 571 - of murine VK21A chain of a monoclonal antibody, - hemoglobin of South American Lungfish (Lepidosi- specific for the group A streptococcal polysaccharide, ren paradoxus), K. Rodewald, A. Stangl and R. Aebersold, Η. Η erbst, J. Y. Chang and G. Braunitzer, 639 D. G.Braun,1385 - of the light-harvesting polypeptide Β 880-/3 (Β 870-/3) - monomeric /3-lactoglobulin I from horse colostrum, of Rhodospirillum rubrum, R. A. Brunisholz, A. Conti, J. Godovac-Zimmermann, J. Lib era- F. Suter and H. Zuber, 675 tori, G. Braunitzer and D. Minori, 1393 - light-harvesting polypeptides of Rhodopseudomonas - of the human free secretory component, H. Eif fert sphaeroides, R. Theiler, F. Suter, V. Wiemken et al., 1489 and H. Zuber, 703 (2-Amino-5,6-dimethylbenzimidazolyI)cobamide, - hemoglobin of the gayal (Bos gaurus frontalis), deamination and reductive deamination, E. Fridrich R. Lalthantluango and G. Braunitzer, 737 and O.Müller, 137 - hemoglobin of the African Elephant (Loxodonta Aminopeptidases, s.a. yeast aminopeptidase I africana), G. Braunitzer, A. Stangl, B. Schrank, - from human leukocytes, W. Rautenberg and C. Krombach and H. Wiesner, 743 H. Tschesche, 49 - 32P-labelled Edman reagent, B.E. Ender, H.-G. Aminopyrine, degradation by enzymes from Phenylo- Gassen and W. Machleid t, 839 bacteria, S. Schmitt, R. Müller, W. Wegst and - of the inhibitor in vipoxin from the venom of F. Lingens, 143 Vipera ammodytes ammodytes, I. Mancheva, Analgesia, opioid activity of [Sar4Jdermorphin-tetra- Τ. Κ lein schmidt, Β. Ale k sie ν and G. Braunitzer, peptide analogues, S. Salvadori, G. Balboni, 885 M. Marastoni, G. Sarto and R. To mat is, 1199 - polypeptides from the phycobilisome of a cyano- Analytical ultracentrifugation, studies on self-associa• bacterium, P. Füglistaller, R. Rümbeli, F. Suter tion of glucose dehydrogenase from Bacillus mega- and H. Zuber, 1085 thrium, D. Schubert, E. Maurer, Κ. Boss and - hemoglobin of the Lowland Tapir (Tapirus terrestris), G. Pfleiderer, 1445 G. Mazur and G. Braunitzer, 1097 Anaphylatoxin, amino-acid sequence of des-Arg^-CSa, - hemoglobin of the White Stork (Ciconia ciconia), B. Zimmermann and W. Vogt, 151 J. Godovac-Zimmermann and G. Braunitzer, Androctonus australis, (a scorpion), immunological 1107 correspondence between hemocyanin subunits of - N-terminus of acid-resistant urinary trypsin in• scorpions and spiders, J. Markl, W. Gebauer, hibitors, K. Hochstrasser, P. Reisinger, G.J. R. Runzler and I. Avissar, 619 Albrecht, E. Wächter and Ö.L. Schönberger, Androgens, progesterone binding and metabolism in 1123 testis microsomes, N. Kühn-Velten, Τ. Bunse, - hemoglobins of two turtles (Chrysemis picta bellii Ν. Schürer and W. Staib, 773 and Phrynops hilarrii), K.P. Rücknagel, E. Reischl Antenna complexes, (of light-harvesting polypeptides), and G. Braunitzer, 1163 of Rhodospirillum rubrum, R. A. Brunisholz, - trypsin inhibitor peptide from Trichosanthes kirilo wii F. Suter and H. Zuber, 675 (Cucurbitaceae), F.-l. Tan, G.-d. Zhang, J.-f. Mu, - of Rhodopseudomonas sphaeroides, R. Theiler, N.-q.LinandC.-w.Chu, 1211 F. Suter, V. Wiemken and H. Zuber, 703 - //-terminus of arginine esterase from Bitis nasicornis Antibodies, (monoclonal), cytoplasmic lectins of venom, F.J. Joubert and E.H. Μ er r if ie Id, 1219 Dictyostelium discoideum, J. Stadler, G. Bauer, - human class II histocompatibility antigens, F. P. M. Westphai and G.Gerisch, 283 Thinnes, G. Egert, H. Götz, Ε. Pauly, P. Altevogt, - (monoclonal from mouse C57B1/6 strain, specific S.Kölbel, P.Wernet, Η. Kratzin, C.-y. Yang and for group A streptococcal polysaccharide), amino- Ν. Hilschmann, 1277 acid sequence of VK25 and VK27 chains, Bd.365(1984) Stichwortregister 1499 R. Aebersold, H. Herbst, T.Grütter, J.Y.Chang Asialo-kallikrein, inhibition, K. Hirano, Y. Okumura, and D.G.Braun, 1375 S. Hay ak aw a, T. Ad ach i and M. Sugiura, 27 - (monoclonal, murine, specific for group A strepto• Aspartate-aminotransferase (EC 2.6.1.1), Chinese coccal polysaccharide), amino-acid sequence of Restaurant Syndrome, K. Folkers, S. Shizukuishi, VK21A chain, R. Aebersold, H. Herbst, J.Y. R. Willis, S. L. Scud der, K.Takemura and Chang and D.G. Braun, 1385 J.B. Longenecker, 405 Anti-elastase screen, human lung secretions, R. A. Association, s. self-association Stockley, H.M. Morrison, S. Smith and Attenuated total reflection infrared spectroscopy, con• T.Tetley,587 formational analyses of light-harvesting polypepti• Antigenic structure, substance P, CS. Cierniewski, des, R. Theiler and H. Zuber, 721 A. Babinska, W.Koziolkiewicz and T.Wasiak, Automated solid-phase sequencing, 32P-labelled Ed- 499 man reagent, B.E.
Load more

Recommended publications
  • 1 ICR-Geneset Gene List
    ICR-geneset Gene List. IMAGE ID UniGene Locus Name Cluster 20115 Hs.62185 SLC9A6 solute carrier family 9 (sodium/hydrogen exchanger), isoform 6 21738 21899 Hs.78353 SRPK2 SFRS protein kinase 2 21908 Hs.79133 CDH8 cadherin 8, type 2 22040 Hs.151738 MMP9 matrix metalloproteinase 9 (gelatinase B, 92kD gelatinase, 92kD type IV collagenase) 22411 Hs.183 FY Duffy blood group 22731 Hs.1787 PHRET1 PH domain containing protein in retina 1 22859 Hs.356487 ESTs 22883 Hs.150926 FPGT fucose-1-phosphate guanylyltransferase 22918 Hs.346868 EBNA1BP2 EBNA1 binding protein 2 23012 Hs.158205 BLZF1 basic leucine zipper nuclear factor 1 (JEM-1) 23073 Hs.284244 FGF2 fibroblast growth factor 2 (basic) 23173 Hs.151051 MAPK10 mitogen-activated protein kinase 10 23185 Hs.289114 TNC tenascin C (hexabrachion) 23282 Hs.8024 IK IK cytokine, down-regulator of HLA II 23353 23431 Hs.50421 RB1CC1 RB1-inducible coiled-coil 1 23514 23548 Hs.71848 Human clone 23548 mRNA sequence 23629 Hs.135587 Human clone 23629 mRNA sequence 23658 Hs.265855 SETMAR SET domain and mariner transposase fusion gene 23676 Hs.100841 Homo sapiens clone 23676 mRNA sequence 23772 Hs.78788 LZTR1 leucine-zipper-like transcriptional regulator, 1 23776 Hs.75438 QDPR quinoid dihydropteridine reductase 23804 Hs.343586 ZFP36 zinc finger protein 36, C3H type, homolog (mouse) 23831 Hs.155247 ALDOC aldolase C, fructose-bisphosphate 23878 Hs.99902 OPCML opioid binding protein/cell adhesion molecule-like 23903 Hs.12526 Homo sapiens clone 23903 mRNA sequence 23932 Hs.368063 Human clone 23932 mRNA sequence 24004
    [Show full text]
  • Fetal and Embryonic Haemoglobins P
    Review Article J Med Genet: first published as 10.1136/jmg.10.1.50 on 1 March 1973. Downloaded from Journal of Medical Genetics (1973). 10, 50. Fetal and Embryonic Haemoglobins P. A. LORKIN MRC Abnormal Haemoglobin Unit, University Department of Biochemistry, Cambridge Haemoglobin has been the subject of intensive form a nearly spherical molecule with extensive research for many years and is one of the most areas of contact between unlike chains; the two thoroughly understood of all protein molecules. main types of contact are denoted alp, and alg2 The amino-acid sequences of haemoglobins from The tetramer exhibits cooperative behaviour or many species of animals have been determined haem-haem interaction. As each haem combines (tabulated by Dayhoff, 1969) and the molecular with oxygen the affinity of successive haems in- structures of horse and human haemoglobins have creases. The oxygen affinity curve of the tetramer been determined in great detail by x-ray crystallo- is sigmoidal and may be represented approximately graphy (Perutz et al, 1968a and b; Perutz 1969). A by the Hill equation:* mechanism of action of haemoglobin has been pro- = kpo2n posed (Perutz, 1970a and b and 1972). The y haemoglobins of higher organisms share a common +kpo2n tetrameric structure built up of two pairs of unlike Oxygen affinity data are usually presented in copyright. chains; the a chains containing 141 amino-acid terms of P102, the partial pressure of oxygen re- residues and the non-a chains containing generally quired to attain half saturation with oxygen, and of 145 or 146 amino acids. In man, five types of n, the exponent of the Hill equation.
    [Show full text]
  • Linkage of Genes for Adult A-Globin and Embryonic Aulike Globin Chains (Hemoglobin H/Thalassemia/Embryonic Hemoglobin/Mice) J
    Proc. Natl. Acad. Sci. USA Vol. 77, No. 2, pp. 1087-1090, February 1980 Genetics Linkage of genes for adult a-globin and embryonic aulike globin chains (hemoglobin H/thalassemia/embryonic hemoglobin/mice) J. BARRY WHITNEY III* AND ELIZABETH S. RUSSELL The Jackson Laboratory, Bar Harbor, Maine 04609 contributed by Elizabeth S. Russell, November 19, 1979 ABSTRACT In a-thalassemia, the genetic locus for the a (Hbaa) female mouse and a triethylene-melamine-treated male chains of adult hemoglobin is not expressed. We have examined that carried a different, doublet, Hba haplotype (5). In this the hemoglobins of a number of individual mouse embryos affected a-thalassemic offspring of the treated male, only the heterozygous for a particular a-thalassemia (Hba th-J) and find n'o.'ecrease in the proportion of hemoglobins containing the Hbaa haplotype inherited from the C57BL/6J mother was a chain as compared to the hemoglobin containing the a-like expressed. The hemoglobins of this mouse were found by embryonic globin chain. This result suggests that the locus for electrophoresis after cystamine treatment (6) to be unusual in this embryonic a-like chain is inactivated or deleted in these that they contained a lower than normal proportion of the he- embryos as well. Because a single mutational event inactivated moglobin containing the diffuse-major:/ chain, a condition also adult and embryonic loci, we conclude that they are probably reported for the x-ray-induced mouse a-thalassemia discovered closely linked to one another on the same chromosome. We also present evidence that an unusual hemoglobin in the blood of at the Oak Ridge National Laboratory (7).
    [Show full text]
  • Steroid Sulfatase of Human Leukocytes and Epidermis and the Diagnosis of Recessive X-Linked Ichthyosis
    Steroid sulfatase of human leukocytes and epidermis and the diagnosis of recessive X-linked ichthyosis. E H Epstein Jr, M E Leventhal J Clin Invest. 1981;67(5):1257-1262. https://doi.org/10.1172/JCI110153. Research Article Patients with recessive X-linked ichthyosis, one of the inherited types of excessive stratum corneum cohesion, have deficient steroid sulfatase in fibroblasts grown from their dermis. Because of the expense and long period required to grow such cells, we have assayed this enzyme in peripheral blood leukocytes and found it to be undetectable in those from patients with this type of ichthyosis, but normal in those from patients with other hereditary or acquired types of ichthyosis. In addition, steroid sulfatase activity is less in leukocytes from women who are carriers of this disease than normal women, and this assay can be used to detect such carriers. Despite previous studies demonstrating that the gene for this enzyme escapes the inactivation of other x-chromosome genes, normal women have leukocyte steroid sulfatase activity only 1.3 times that of normal men, suggesting that some gene dosage compensation occurs. Normal human epidermis, the tissue most affected clinically, also expresses steroid sulfatase activity. The epidermal enzyme is similar in its subcellular localization, its molecular size, and kinetically to that of placenta, leukocytes, and fibroblasts. Find the latest version: https://jci.me/110153/pdf Steroid Sulfatase of Human Leukocytes and Epidermis and the Diagnosis of Recessive X-linked Ichthyosis ERVIN H. EPSTEIN, JR., and MARY E. LEVENTHAL, Dermatology Unit of the Medical Service, San Francisco General Hospital Medical Center, Department of Dermatology, University of California, San Francisco, California 94110 A B S T R A C T Patients with recessive X-linked pearance especially on the side of the neck, and the ichthyosis, one of the inherited types of excessive subsequently described comeal stippling (2).
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2003/0082511 A1 Brown Et Al
    US 20030082511A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2003/0082511 A1 Brown et al. (43) Pub. Date: May 1, 2003 (54) IDENTIFICATION OF MODULATORY Publication Classification MOLECULES USING INDUCIBLE PROMOTERS (51) Int. Cl." ............................... C12O 1/00; C12O 1/68 (52) U.S. Cl. ..................................................... 435/4; 435/6 (76) Inventors: Steven J. Brown, San Diego, CA (US); Damien J. Dunnington, San Diego, CA (US); Imran Clark, San Diego, CA (57) ABSTRACT (US) Correspondence Address: Methods for identifying an ion channel modulator, a target David B. Waller & Associates membrane receptor modulator molecule, and other modula 5677 Oberlin Drive tory molecules are disclosed, as well as cells and vectors for Suit 214 use in those methods. A polynucleotide encoding target is San Diego, CA 92121 (US) provided in a cell under control of an inducible promoter, and candidate modulatory molecules are contacted with the (21) Appl. No.: 09/965,201 cell after induction of the promoter to ascertain whether a change in a measurable physiological parameter occurs as a (22) Filed: Sep. 25, 2001 result of the candidate modulatory molecule. Patent Application Publication May 1, 2003 Sheet 1 of 8 US 2003/0082511 A1 KCNC1 cDNA F.G. 1 Patent Application Publication May 1, 2003 Sheet 2 of 8 US 2003/0082511 A1 49 - -9 G C EH H EH N t R M h so as se W M M MP N FIG.2 Patent Application Publication May 1, 2003 Sheet 3 of 8 US 2003/0082511 A1 FG. 3 Patent Application Publication May 1, 2003 Sheet 4 of 8 US 2003/0082511 A1 KCNC1 ITREXCHO KC 150 mM KC 2000000 so 100 mM induced Uninduced Steady state O 100 200 300 400 500 600 700 Time (seconds) FIG.
    [Show full text]
  • Steroid Sulfatase Stimulates Intracrine Androgen Synthesis and Is a Therapeutic Target for Advanced Prostate Cancer
    Author Manuscript Published OnlineFirst on September 14, 2020; DOI: 10.1158/1078-0432.CCR-20-1682 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Steroid sulfatase stimulates intracrine androgen synthesis and is a therapeutic target for advanced prostate cancer Cameron M. Armstrong1*, Chengfei Liu1*, Liangren Liu1,2*, Joy C. Yang1, Wei Lou1, Ruining Zhao1,3, Shu Ning1, Alan P. Lombard1, Jinge Zhao1, Leandro S D'Abronzo1, Christopher P. Evans1,4, Pui-Kai Li5, Allen C. Gao1, 4, 6,7 Running title: Targeting steroid sulfatase for advanced prostate cancer Key words: Prostate cancer, steroid sulfatase, resistance, intracrine androgen synthesis, adrenal androgens 1Department of Urologic Surgery, University of California Davis, CA, USA 2Present address: Department of Urology, West China Hospital, Sichuan University, China 3Present address: Department of Urology, General Hospital of Ningxia Medical University, China 4UC Davis Comprehensive Cancer Center, University of California Davis, CA, USA 5Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH, USA 6VA Northern California Health Care System, Sacramento, CA, USA 7Corresponding author: Allen Gao, University of California Davis, 4645 2nd Avenue, Sacramento, CA 95817, USA. Phone: 916-734-8718, email: [email protected] *These authors contributed equally to the work. Conflict of interest: PKL and ACG are co-inventors of a patent application of the selected small molecule inhibitors of steroid sulfatase. 1 Downloaded from clincancerres.aacrjournals.org on October 1, 2021. © 2020 American Association for Cancer Research. Author Manuscript Published OnlineFirst on September 14, 2020; DOI: 10.1158/1078-0432.CCR-20-1682 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
    [Show full text]
  • REVIEW Steroid Sulfatase Inhibitors for Estrogen
    99 REVIEW Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers Atul Purohit and Paul A Foster1 Oncology Drug Discovery Group, Section of Investigative Medicine, Imperial College London, Hammersmith Hospital, London W12 0NN, UK 1School of Clinical and Experimental Medicine, Centre for Endocrinology, Diabetes and Metabolism, University of Birmingham, Birmingham B15 2TT, UK (Correspondence should be addressed to P A Foster; Email: [email protected]) Abstract Estrogens and androgens are instrumental in the maturation of in vivo and where we currently stand in regards to clinical trials many hormone-dependent cancers. Consequently,the enzymes for these drugs. STS inhibitors are likely to play an important involved in their synthesis are cancer therapy targets. One such future role in the treatment of hormone-dependent cancers. enzyme, steroid sulfatase (STS), hydrolyses estrone sulfate, Novel in vivo models have been developed that allow pre-clinical and dehydroepiandrosterone sulfate to estrone and dehydroe- testing of inhibitors and the identification of lead clinical piandrosterone respectively. These are the precursors to the candidates. Phase I/II clinical trials in postmenopausal women formation of biologically active estradiol and androstenediol. with breast cancer have been completed and other trials in This review focuses on three aspects of STS inhibitors: patients with hormone-dependent prostate and endometrial 1) chemical development, 2) biological activity, and 3) clinical cancer are currently active. Potent STS inhibitors should trials. The aim is to discuss the importance of estrogens and become therapeutically valuable in hormone-dependent androgens in many cancers, the developmental history of STS cancers and other non-oncological conditions.
    [Show full text]
  • WO 2017/070364 Al 27 April 2017 (27.04.2017) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2017/070364 Al 27 April 2017 (27.04.2017) P O P C T (51) International Patent Classification: AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, A61K 39/395 (2006.01) C07K 16/18 (2006.01) BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, C07K 16/00 (2006.01) DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, (21) International Application Number: KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, PCT/US20 16/057942 MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (22) International Filing Date: OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, 20 October 2016 (20.10.201 6) SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (25) Filing Language: English ZW. (26) Publication Language: English (84) Designated States (unless otherwise indicated, for every (30) Priority Data: kind of regional protection available): ARIPO (BW, GH, 62/244,655 2 1 October 2015 (21. 10.2015) US GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, (71) Applicant: QOOLABS, INC. [US/US]; 4186 Sorrento TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, Valley Blvd., Suite D/E, San Diego, CA 92121 (US).
    [Show full text]
  • Sourcebook in Forensic Serology, Immunology, and Biochemistry
    UNIT VII. HEMOGLOBIN, SERUM GROUP SYSTEMS, HLA AND OTHER GENETIC MARKERS Hemoglobin SECTION 38. HEMOGLOBIN 38.1 Introduction Hemoglobin (Hb)is the major protein of human red cells, forth. Hemoglobins exist which contain only one kind of comprising about 95% of their dry weight. Adult human chain: Hb H is B4, for example, and Hb Bart's is 7,. blood normally contains from about 4 million to 6.5 million Jones (1961) pointed out that hemoglobin structural red cells per mm3 blood, the average figure being slightly heterogeneity can be classified as follows: (1) Maturation higher for men. Hemoglobin itself is present in concentra- heterogeneity, which refers to the fact that different tions of about 14 to 16 g per 100 mP blood. It is the oxygen hemoglobins are normally synthesized during different transporting protein in higher animals; without a molecule stages of development. There are embryonic, fetal and adult having its properties, complex multicellular aerobic life as hemoglobins. (2) Minor hemoglobin heterogeneity, which we know it would not be possible. refers to the presence of small amounts of structurally dif- Hemoglobin is one of the most extensively studied of all ferent but normal hemoglobins along with the major proteins, and its literature fills many volumes. As noted in component characteristic of a particular stage of develop- section 5.1, it acquired its present name over 100 years ago ment; and (3) genetic heterogeneity, which refers to the (Hoppe-Seyler, 1864). In forensic serology, hemoglobiin is various "abnormal" hemoglobin variants. Many of these important in two principal contexts: (1) Blood is normally are thought to be the result of point mutations, and with a idenad in questioned samples by procedures designed to few exceptions, variant hemoglobins are very rare.
    [Show full text]
  • Mitochondrial Dysfunction and Organic Aciduria In
    Mitochondrial dysfunction and organic aciduria in five patients carrying mutations in the Ras-MAPK pathway Eva Morava, Tjitske Kleefstra, Saskia Wortmann, Richard Rodenburg, Ernie Mhf Bongers, Kinga Hadzsiev, Lambert van den Heuvel, Willy M Nillessen, Katalin Hollody, Martin Lammens, et al. To cite this version: Eva Morava, Tjitske Kleefstra, Saskia Wortmann, Richard Rodenburg, Ernie Mhf Bongers, et al.. Mitochondrial dysfunction and organic aciduria in five patients carrying mutations in the Ras-MAPK pathway. European Journal of Human Genetics, Nature Publishing Group, 2010, 10.1038/ejhg.2010.171. hal-00591692 HAL Id: hal-00591692 https://hal.archives-ouvertes.fr/hal-00591692 Submitted on 10 May 2011 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Mitochondrial dysfunction and organic aciduria in five patients carrying mutations in the Ras-MAPK pathway Running title: mutations in MAPK and mitochondrial dysfunction Tjitske Kleefstra1+, Saskia B. Wortmann2+, Richard J.T. Rodenburg2,3, Ernie M.H.F. Bongers1, Kinga Hadzsiev4, Cees Noordam5, Lambert
    [Show full text]
  • Chromosomal Microarray, Postnatal, Clarisure® Oligo-SNP
    Diagnostic Services Pediatrics Test Summary Chromosomal Microarray, Postnatal, ClariSure® Oligo-SNP The American College of Medical Genetics (ACMG) Test Code: 16478(X) recommends CMA testing as a first-line genetic test for developmental delay, intellectual disability, ASDs, and Specimen Requirements: 10 mL room-temperature whole multiple congenital anomalies.2,4 This recommendation blood (sodium-heparin, green-top tube); 5 mL minimum is based, in part, on a literature review that included over 21,000 patients with developmental delay/intellectual CPT Code*: 81229 disability, ASDs, or multiple congenital anomalies. The diagnostic yield was 15% to 20% for CMA testing versus ~3% for G-banded karyotyping and ~6% for subtelomeric Clinical Use fluorescence in situ hybridization (FISH) in combination • Determine the genetic etiology of developmental with G-banded karyotyping.5 In individuals with complex delay, intellectual disability, autism spectrum disorders ASDs, CMA testing can result in a diagnostic yield of over (ASDs; pervasive developmental disorders), and 25%.2 ACMG still considers karyotyping a first-line test multiple congenital anomalies when patients are suspected of having a recognizable • Confirm or exclude the diagnosis of known chromosomal syndrome such as trisomy 21 or 18, Turner chromosomal syndromes syndrome, or Klinefelter syndrome.2,4 • Further define ambiguities arising from cytogenetic The oligonucleotide-single nucleotide polymorphism or FISH studies (oligo-SNP) array contains over 2.6 million probes and • Assist in clinical management and genetic counseling covers regions of known and likely CNVs. It can confirm the diagnosis of suspected disorders associated with known Clinical Background chromosomal syndromes and is especially well suited Global developmental delay, intellectual disability (mental for determining the genetic cause of less well-described retardation), ASDs, and multiple congenital anomalies may disorders.
    [Show full text]
  • Design, Synthesis, and Evaluation of Inhibitors of Steroid Sulfatase
    Design, synthesis, and evaluation of inhibitors of steroid sulfatase by Yaser Abdel-Hady Mostafa Abdel-Karem A thesis Presented to the University of Waterloo in fulfilment of the thesis requirement for the degree of Doctor of Philosophy in Chemistry Waterloo, Ontario, Canada, 2014 © Yaser Abdel-Hady Mostafa Abdel-Karem 2014 i Author’s Declaration I hereby declare that I am the sole author of this thesis. This is a true copy of the thesis, including any required final revisions, as accepted by examiners. I understand that my thesis may be made electronically available to public. ii Abstract Steroid sulfatase (STS) catalyzes the desulfation of biologically inactive sulfated steroids to yield biologically active desulfated steroids and is currently being examined as a target for therapeutic intervention for the treatment of breast and other steroid-dependent cancers. A series of 17-arylsulfonamides of 17-aminoestra-1,3,5(10)-trien-3-ol were prepared and evaluated as inhibitors of STS. Introducing n-alkyl groups into the 4´-position of the 17- benzenesulfonamide derivative resulted in an increase in potency with the n-butyl derivative exhibiting the best potency with an IC50 of 26 nM. A further increase in carbon units (to n- pentyl) resulted in a decrease in potency. Branching of the 4´-n-propyl group resulted in a decrease in potency while branching of the 4´-n-butyl group (to a tert-butyl group) resulted in a slight increase in potency (IC50 = 18 nM). Studies with 17-benzenesulfonamides substituted at the 3´- and 4´-positions with small electron donating and electron withdrawing groups revealed the 3´-bromo and 3´-trifluoromethyl derivatives to be excellent inhibitors with IC50‘s of 30 and 23 nM respectively.
    [Show full text]